# Xerox Holdings Corp: filings

XRX · Nasdaq · CIK 1770450 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xrx.md) · [Financials](/companies/xrx/financials.md) · [Filings](/companies/xrx/filings.md) · [Insiders](/companies/xrx/insiders.md)

## Reports and events: 168 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 328, 8-K 106, 3 24, 10-Q 22, 4/A 20, SC 13D/A 17, SC 13G/A 14, 144 13, 10-K 7, DEF 14A 7, SD 7, S-8 6, DEFA14A 5, SC 13G 5, SCHEDULE 13G/A 5, ARS 4, SCHEDULE 13D/A 4, CORRESP 3, S-8 POS 3, SCHEDULE 13D 3, 8-A12B 2, 8-K/A 2, CERT 2, EFFECT 2, S-4 2, S-4/A 2, SEC STAFF LETTER 2, UPLOAD 2, 25 1, 424B2 1, 424B3 1, 424B5 1, 425 1, 8-K12B 1, NT 10-K 1, PRE 14A 1, PREM14A 1, RW 1, S-3 1, S-3/A 1, S-3ASR 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 08:04 ET | [8-K](/filings/0001193125-26-437046.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-437046 |
| 2026-10-29 | 07:52 ET | [8-K](/filings/0001770450-26-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770450-26-000044 |
| 2026-09-08 | 09:10 ET | [SCHEDULE 13D/A](/filings/0001493152-26-041719.md) | Ownership report, active investor, amended | 0001493152-26-041719 |
| 2026-08-06 | 16:48 ET | [10-Q](/filings/0001770450-26-000040.md) | Quarterly report, period 2026-06-30 | 0001770450-26-000040 |
| 2026-07-30 | 06:44 ET | [8-K](/filings/0001770450-26-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770450-26-000034 |
| 2026-07-13 | 17:44 ET | [SCHEDULE 13D/A](/filings/0001493152-26-033090.md) | Ownership report, active investor, amended | 0001493152-26-033090 |
| 2026-07-02 | 16:05 ET | [8-K](/filings/0001193125-26-294480.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-294480 |
| 2026-06-03 | 16:05 ET | [SCHEDULE 13D/A](/filings/0001493152-26-027042.md) | Ownership report, active investor, amended | 0001493152-26-027042 |
| 2026-05-27 | 16:07 ET | [8-K](/filings/0001193125-26-241888.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-241888 |
| 2026-05-14 | 16:05 ET | [SCHEDULE 13D](/filings/0001493152-26-023060.md) | Ownership report, active investor | 0001493152-26-023060 |
| 2026-05-07 | 16:38 ET | [10-Q](/filings/0001770450-26-000030.md) | Quarterly report, period 2026-03-31 | 0001770450-26-000030 |
| 2026-04-30 | 06:40 ET | [8-K](/filings/0001770450-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770450-26-000025 |
| 2026-04-08 | 09:50 ET | [SCHEDULE 13D](/filings/0001104659-26-040727.md) | Ownership report, active investor | 0001104659-26-040727 |
| 2026-04-08 | 09:50 ET | [SCHEDULE 13D](/filings/0001104659-26-040725.md) | Ownership report, active investor | 0001104659-26-040725 |
| 2026-04-07 | 17:18 ET | [DEF 14A](/filings/0001770450-26-000020.md) | Proxy statement, period 2025-12-31 | 0001770450-26-000020 |
| 2026-04-02 | 17:26 ET | [8-K](/filings/0001193125-26-140584.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-140584 |
| 2026-03-17 | 18:59 ET | [10-K](/filings/0001770450-26-000009.md) | Annual report, period 2025-12-31 | 0001770450-26-000009 |
| 2026-02-17 | 09:23 ET | [8-K](/filings/0001193125-26-053333.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-053333 |
| 2026-02-13 | 13:37 ET | [SCHEDULE 13D/A](/filings/0001104659-26-015032.md) | Ownership report, active investor, amended | 0001104659-26-015032 |
| 2026-02-12 | 08:09 ET | [8-K](/filings/0001193125-26-047741.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-047741 |
| 2026-01-29 | 06:35 ET | [8-K](/filings/0001770450-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770450-26-000003 |
| 2026-01-28 | 08:15 ET | [8-K](/filings/0001193125-26-026118.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-026118 |
| 2026-01-21 | 21:17 ET | [8-K](/filings/0001193125-26-017037.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-017037 |
| 2025-12-09 | 17:11 ET | [8-K](/filings/0001193125-25-312947.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-312947 |
| 2025-11-19 | 17:16 ET | [8-K](/filings/0001193125-25-288323.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001193125-25-288323 |
| 2025-11-10 | 16:42 ET | [10-Q](/filings/0001770450-25-000037.md) | Quarterly report, period 2025-09-30 | 0001770450-25-000037 |
| 2025-10-30 | 06:35 ET | [8-K](/filings/0001770450-25-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770450-25-000033 |
| 2025-08-15 | 16:39 ET | [8-K](/filings/0001193125-25-181917.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-181917 |
| 2025-08-07 | 17:02 ET | [10-Q](/filings/0001628280-25-038980.md) | Quarterly report, period 2025-06-30 | 0001628280-25-038980 |
| 2025-07-31 | 06:32 ET | [8-K](/filings/0001628280-25-036814.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-036814 |
| 2025-07-31 | 20:04 ET | [8-K/A](/filings/0001193125-25-169607.md) | 9.01 Financial statements and exhibits | 0001193125-25-169607 |
| 2025-07-02 | 17:06 ET | [8-K](/filings/0001193125-25-155007.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-155007 |
| 2025-05-27 | 16:47 ET | [8-K](/filings/0001193125-25-127623.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-127623 |
| 2025-05-12 | 16:37 ET | [10-Q](/filings/0001770450-25-000026.md) | Quarterly report, period 2025-03-31 | 0001770450-25-000026 |
| 2025-05-09 | 16:51 ET | [8-K](/filings/0001193125-25-116939.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-116939 |
| 2025-05-07 | 07:00 ET | [8-K](/filings/0001193125-25-114424.md) | 7.01 Regulation FD disclosure | 0001193125-25-114424 |
| 2025-05-01 | 06:36 ET | [8-K](/filings/0001770450-25-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770450-25-000021 |
| 2025-04-11 | 16:40 ET | [8-K](/filings/0001193125-25-079163.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-079163 |
| 2025-04-09 | 16:31 ET | [DEF 14A](/filings/0001770450-25-000017.md) | Proxy statement, period 2024-12-31 | 0001770450-25-000017 |
| 2025-03-25 | 14:28 ET | [8-K](/filings/0001193125-25-062401.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-062401 |
| 2025-02-24 | 16:38 ET | [10-K](/filings/0001770450-25-000010.md) | Annual report, period 2024-12-31 | 0001770450-25-000010 |
| 2025-02-05 | 17:03 ET | [8-K/A](/filings/0001770450-25-000006.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001770450-25-000006 |
| 2025-01-28 | 06:35 ET | [8-K](/filings/0001770450-25-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770450-25-000003 |
| 2025-01-21 | 18:18 ET | [8-K](/filings/0001193125-25-008605.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-008605 |
| 2024-12-23 | 07:17 ET | [8-K](/filings/0001193125-24-283670.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-283670 |
| 2024-11-21 | 08:59 ET | [8-K](/filings/0001193125-24-263043.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-263043 |
| 2024-11-04 | 16:39 ET | [10-Q](/filings/0001770450-24-000050.md) | Quarterly report, period 2024-09-30 | 0001770450-24-000050 |
| 2024-10-29 | 06:37 ET | [8-K](/filings/0001770450-24-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770450-24-000045 |
| 2024-10-17 | 09:15 ET | [8-K](/filings/0001193125-24-238574.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-238574 |
| 2024-09-18 | 21:39 ET | [8-K](/filings/0001193125-24-220895.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-220895 |

Page 1 of 4. [Older](/companies/xrx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 08:06 ET. No prices; not investment advice.